Table 1.
Patient demographics and characteristics
| n | Nondiabetic | Diabetic | |
|---|---|---|---|
| Demographics | |||
| Age, yr | 60.0 ± 1.9 | 61.2 ± 1.8 | |
| Sex (M/F) | 38/9 | 22/12 | |
| Race | Caucasian | Caucasian | |
| Characteristics | |||
| BMI | 29.8 ± 0.8 | 32.8 ± 1.1* | |
| HbA1c | 35, 33 | 5.5 ± 0.1 | 8.5 ± 0.4* |
| Avgerage BG | 37, 32 | 111.8 ± 2.4 | 199.2 ± 12.2* |
| EF | 52.8 ± 2.1 | 49.2 ± 2.7 | |
| Hypertension, % | 46, 34 | 78.3 | 85.3 |
| CAD, % | 47, 34 | 83.0 | 91.2 |
| Medications | |||
| Insulin | 0/47 | 12/34 | |
| Metformin | 0/47 | 13/34 | |
| Sulfonylureas | 0/47 | 6/34 | |
| β-Blockers | 28/47 | 26/34 | |
| ACE inhibitors | 15/47 | 17/34 | |
| Statins | 27/47 | 20/34 |
Values are means ± SE; n, number of patients. BMI, body mass index; HbA1c, glycated hemoglobin; BG, blood glucose, EF, ejection fraction; CAD, coronary artery disease; ACE, angiotensin-converting enzyme.
*
P ≤ 0.05 diabetic vs. nondiabetic group.